Amarin Corporation PLC (AMRN)

Amarin Corporation PLC (AMRN) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $261M; returns 1 day +1.6%, 1 week +4.2%, 1 year -39.4%.

Amarin Corporation PLC, founded in 1993, is a biopharmaceutical company headquartered in Dublin, Ireland, and Bridgewater, New Jersey. It focuses on developing and commercializing therapeutics to improve cardiovascular health and reduce cardiovascular risk. Amarin's main product is Vascepa (icosapent ethyl), a prescription-only omega-3 fatty acid.

Groups AMRN belongs to

• Biotechnology
• Pharmaceuticals
• Cardiovascular Therapies
• Healthcare
• Biopharmaceutical
• Commercial Stage
• Commercial Stage Biotech
• Life Sciences

AMRN financial model: income statement, cash flow and balance sheet